Topics
Gliomas | Treatment | Side-effects | Epilepsy
Home > Publications > Topics > Gliomas > Treatment > Side-effects > Epilepsy
Liang R, Hu C, Li H, Tang X.
Research
trends of glioma-related epilepsy: A bibliometric analysis from
2004 to 2023.
J
Cent Nerv Syst Dis. 2024 Oct 16;16:11795735241286653.
doi:
10.1177/11795735241286653. PMID:
39420955. Bibliometric analysis. ˍ
Michelucci R, Pauletto G, Silvani A, Pasini E, Ius T, Martinoni M,
Castioni CA, Salmaggi A, Asioli S, Maschio M, Minniti G,
Franceschi E, Villani F, Rudà R, Aronica E; Italian
Multidisciplinary Group for Tumor Epilepsy.
Tumor-related
epilepsy in glioma: A multidisciplinary overview.
Epilepsia.
2025 Jul 5. doi:
10.1111/epi.18523. PMID:
40616791. Review. ˍ
Shukla PD, Nguyen MP, Lee AT, Chang EF, Young JS.
Management
of glioma-associated epilepsy in the molecular era: a review of
the literature and an institutional experience.
Neurosurg
Focus. 2025 Aug 1;59(2):E11. doi:
10.3171/2025.5.FOCUS25334. PMID:
40749243. Review. ˍ
Chen X, Yang JZ, Kong LY, Li ZY, Tang F, Li ZQ.
Research
progress in glioma-related epilepsy (Review).
Biomed
Rep. 2025 Aug 19;23(4):167. doi:
10.3892/br.2025.2045. PMID:
40900975. Review. ˍ
Jenkinson MD, Bulbeck H, Burns J, Rooney AG, Dobbie R, Carruthers
J, Lessels S, Watson R, Gribben C, Robinson T, Vale L, Thompson G,
Erridge SC, Watts C, Marson AG, Grant R; SPRING study
Collaborators.
Seizure prophylaxis
in glioma surgery (SPRING): A multi-center, unblinded, randomized
trial.
Neurooncol
Pract. 2025 Nov 5;13(2):252-261. doi:
10.1093/nop/npaf114. PMID:
42111024. Trial
registration ID: ISRCTN 49474281, EudraCT
2018-001312-30. ˍ